|
|||||
|
|
Pregnancy outcomes following exposure to onabotulinumtoxinA |
|
| Authors: | Mitchell F. Brin Russell S. Kirby Anne Slavotinek Mary Ann Miller‐Messana Lori Parker Irina Yushmanova Huiying Yang |
| Affiliation: | 1. Allergan, Inc., Irvine, CA, USA;2. University of California, Irvine, CA, USA;3. University of South Florida, Tampa, FL, USA;4. University of California, San Francisco, CA, USA;5. Now at the Department of Drug Safety and Pharmacovigilance, Pharmacyclics, Inc., Sunnyvale, CA, USA |
| Abstract: | |
| Keywords: | onabotulinumtoxinA pregnancy fetal defects pharmacoepidemiology |